Lipid Clinics Network. Rationale and design of the EAS global project

Asiiat S. Alieva, Lale Tokgözoğlu, Kausik K. Ray, Alberico L. Catapano

Research output: Contribution to journalArticlepeer-review


The evidence of the causal role of low-density lipoprotein cholesterol in the development of atherosclerotic cardiovascular disease is well-established. The clearly identified common position of the European guidelines proclaims necessity to decrease LDL-C concentrations based on a proper risk stratification. However, current worldwide situation with the lipid management still demonstrates inadequate dyslipidemia control, that is probably related to a healthcare system issues. As the need to standardize and implement approaches following the guidelines into clinical practice remains a challenge, the EAS initiates the Lipid Clinics Network project, aiming to provide a structure to establish uniform EU-wide standards of diagnosis, management and treatment of patients with lipid disorders, based on the ESC/EAS Guidelines on management of dyslipidaemias.

Original languageEnglish
Pages (from-to)e6-e8
JournalAtherosclerosis Supplements
Publication statusPublished - Dec 2020


  • Cardiovascular risk
  • Dyslipidemia
  • European guidelines
  • Risk management

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Lipid Clinics Network. Rationale and design of the EAS global project'. Together they form a unique fingerprint.

Cite this